Drug intelligence / Profile preview

grape polyphenols

Development stage: Preclinical
Lead developer: Polyphenolics
Modality: Small Molecules
Administration: Oral

Overview

Grape polyphenols are a class of bioactive compounds found in grapes, known for their antioxidant, anti-inflammatory, antimicrobial, cardioprotective, and anticancer properties. They include anthocyanins, flavanols, flavonols, and resveratrol, which are primarily located in the skin, seeds, and stems of grapes. These compounds have been studied for their potential health benefits, including reducing the risk of cardiovascular diseases and certain cancers, and managing metabolic disorders.

Other names: grape polyphenol extractgrape polyphenol supplementsgrape-derived polyphenols

Targets

Tau aggregates (Microtubule-associated protein tau (pathological form))Amyloid-beta aggregate (N-terminal epitope)

Beyond the preview

Go deeper on grape polyphenols.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on grape polyphenols.

Explore the full profile